| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/29/2007 | EP1694656B1 Benzoxazine derivatives and uses thereof |
| 08/29/2007 | EP1643998B1 Dual nk1/nk3 antagonists for treating schizophrenia |
| 08/29/2007 | EP1562938B1 Heteroaryl-pyrimidine derivatives as jak inhibitors |
| 08/29/2007 | EP1506167B1 Hydroxy tetrahydro-naphthalenylurea derivatives |
| 08/29/2007 | EP1412368B1 Sugar derivatives of hydromorphone, dihydromorphine and dihydroisomorphine, compositions thereof and uses for treating or preventing pain |
| 08/29/2007 | EP1351934B1 Naphthalene derivatives which bind to the ep4 receptor |
| 08/29/2007 | EP1333840B9 M. tuberculosis chaperonin 60.1 and uses thereof |
| 08/29/2007 | EP1236046B1 Methods for screening compounds active on neurons |
| 08/29/2007 | EP1096932B1 Antihypertensive combination of valsartan and calcium channel blocker |
| 08/29/2007 | EP1054963B1 Sequences of an ih ionic channel and the use thereof |
| 08/29/2007 | EP0935657B1 Modified steroid hormone receptors |
| 08/29/2007 | CN101027390A Lrp4/Corin dopamine-producing neuron precursor cell marker |
| 08/29/2007 | CN101027320A FGFR binding peptides |
| 08/29/2007 | CN101027319A 肝素结合肽 Heparin-binding peptides |
| 08/29/2007 | CN101027301A Fused ring azadecalin glucocorticoid receptor modulators |
| 08/29/2007 | CN101027300A Novel azabicyclic aryl derivatives and their medical use |
| 08/29/2007 | CN101027297A Macrocyclic beta-secretase inhibitors |
| 08/29/2007 | CN101027294A Phenyl DIAZEPAN carboxamides and annelated phenyl piperazine carboxamides containing oxygen and used as dopamine D3 antagonists |
| 08/29/2007 | CN101027292A Compounds, compositions containing them, preparation thereof and uses thereof |
| 08/29/2007 | CN101027291A Benzimidazole derivatives and their use as cannabinoid receptor ligands |
| 08/29/2007 | CN101024628A Aza-flavones, its preparing method and use |
| 08/29/2007 | CN101024622A Theanine amino-acid salt, its preparing method and use |
| 08/29/2007 | CN101024067A Medicine for treating facial nerve paralysis |
| 08/29/2007 | CN101024047A 3-D incense therapy rod |
| 08/29/2007 | CN101024046A Navel therapeutic sleep-fat-reducing fat gasifying ointment for redically treating fat |
| 08/29/2007 | CN101024040A Medicine preparation for invigorating intelligence and recovering paralysis |
| 08/29/2007 | CN101024027A Plaster for treating rheumatism bone disease and its preparing |
| 08/29/2007 | CN101024019A Gouzhi hemolysis soup |
| 08/29/2007 | CN101024016A Chinese for treating infaut's attention deficit hyperactivity disorder |
| 08/29/2007 | CN101023998A Anermian tablets and its preparing method |
| 08/29/2007 | CN101023967A Compound extract of common phellinus fungus and chaga, its preparing method and preparation |
| 08/29/2007 | CN101023964A Method for preparing brain tissue injure |
| 08/29/2007 | CN101023948A Rimonabant and cyclodextrin inclusion compound of its salt capable of being as medicine, its preparing method and medicine use |
| 08/29/2007 | CN101023946A Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 08/29/2007 | CN101023944A Use of indirubin derivative for preparing medicines for treating nerve retrograde affection |
| 08/29/2007 | CN100334109C GLP-1 analogues |
| 08/29/2007 | CN100334082C Novel preparation process for 2 - methyl piperazine derivatives |
| 08/29/2007 | CN100334076C Indoline derivatives and their use as 5-HT2 receptor ligands |
| 08/29/2007 | CN100333798C Naloxone eye drops |
| 08/29/2007 | CN100333759C Pellet for nourish the brain and benefiting intelligence |
| 08/29/2007 | CN100333731C Application of astragaloside in preparing medication for treating peripheral nervous lesion of diabetes |
| 08/29/2007 | CN100333723C Iontophoretic delivery of rotigotine for the treatment of parkinson's disease |
| 08/29/2007 | CN100333721C Levodopa nano preparation and its preparing method |
| 08/29/2007 | CN100333720C Compound analgesic agent |
| 08/28/2007 | US7262309 Cyclization at the 5,6-position of the benzo[e]naphtho[3,2-h]azulene, oxepane or thiepane with a mercaptoacetic acid ester followed by etherification, amination or sulfiding at the 2-position; antiarthritic and antiinflammatory agents, analgesics; biosynthesis inhibitors of interleukin-1 |
| 08/28/2007 | US7262302 Antiinflammatory action; rheumatoid arthritis |
| 08/28/2007 | US7262277 Antagonistic anti-hFAS ligand human antibodies and fragments thereof |
| 08/28/2007 | US7262219 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
| 08/28/2007 | US7262216 Benzofuran compounds and their use as antidepressants and anxiolytics |
| 08/28/2007 | US7262215 N-carbacycle monosubstituted indolocarbazoles as protein kinase inhibitors |
| 08/28/2007 | US7262208 Hydroxypropyl amides for the treatment of Alzheimer's disease |
| 08/28/2007 | US7262194 Therapeutic agents useful for treating pain |
| 08/28/2007 | US7262191 Benzothiadiazine compounds |
| 08/28/2007 | US7262190 Benzothiazine and benzothiadiazine compounds |
| 08/28/2007 | US7262189 Cognition activators; neurodegenerative diseases; anxiolytic agents;psychological disorders; alzheimer's disease; Huntington's disease; antiischemic agents; antiepileptic agenst |
| 08/28/2007 | US7262188 Phenyl sulfone derivatives and their use in the treatment of CNS disorders |
| 08/28/2007 | US7262052 DNA sequence that encodes a polypeptide that is a voltage activated calcium channel alpha 2 delta -C subunit |
| 08/28/2007 | US7261907 Administering to an animal subject in need thereof an effective amount of a composition comprising a clathrate of aliphatic material and monoclinic sulfur, wherein the aliphatic material is encapsulated by the monoclinic sulfur |
| 08/28/2007 | CA2485337C Analgesic composition and method |
| 08/28/2007 | CA2342198C Therapeutic agent for spinal canal stenosis |
| 08/28/2007 | CA2278507C Method for treatment of cns-involved lysosomal storage diseases |
| 08/28/2007 | CA2184727C Proteasome regulation of nf-kb activity |
| 08/23/2007 | WO2007095618A2 Benzo-fused heterocycle sulfamide derivatives for the treatment of migraine |
| 08/23/2007 | WO2007095617A1 Use of benzo-heteroaryl sulfamide derivatives for the treatment of substance abuse and addiction |
| 08/23/2007 | WO2007095613A2 Use of benzo-heteroaryl sulfamide derivatives as neuroprotective agents |
| 08/23/2007 | WO2007095606A1 Use of benzo-heteroaryl sulfamide derivatives for the treatment of depression |
| 08/23/2007 | WO2007095513A1 Tetrahydr0-2h-indaz0le derivatives for use as cannabinoid modulators |
| 08/23/2007 | WO2007095424A1 Novel tricyclic dihydropyrazines as potassium channel openers |
| 08/23/2007 | WO2007095223A2 Pyrrolo(3,2-c) pyridines useful as inhibitors of protein kinases |
| 08/23/2007 | WO2007095147A2 Adhesive preparation comprising sufentanil and methods of using the same |
| 08/23/2007 | WO2007095024A1 Metabotropic glutamate receptor-potentiating γsoindolones |
| 08/23/2007 | WO2007094718A1 Radioligands for the 5 -ht1b receptor |
| 08/23/2007 | WO2007094694A1 Use of 5h-dibenz/b,f/azepine-5-carboxamide derivatives in the treatment of neuropathic pain and neurological disorders |
| 08/23/2007 | WO2007094668A1 Affinity regions |
| 08/23/2007 | WO2007094423A1 Human monoclonal antibody capable of binding to human cytomegalovirus, and antigen-binding domain of the antibody |
| 08/23/2007 | WO2007094385A1 Adhesive patch for external use with improved cohesive force and sustained-release characteristics |
| 08/23/2007 | WO2007094166A1 Therapeutic agent for spinal cord injury |
| 08/23/2007 | WO2007094027A2 Methods for the diagnosis of proliferative and/or conformational diseases |
| 08/23/2007 | WO2007094026A1 Prophylactic and/or therapeutic treatment of proliferative and conformational diseases |
| 08/23/2007 | WO2007093909A1 Novel pharmaceutical compositions for optimizing substitution treatments and extending the pharmacopoeia to global treatment of addictions |
| 08/23/2007 | WO2007093880A2 Novel pyrone-indole derivatives and process for their preparation |
| 08/23/2007 | WO2007093624A2 Pharmaceutical compositions for the treatment of attention deficit hyperactivity disorder comprising flibanserin |
| 08/23/2007 | WO2007093603A1 1-phenethylpiperidine derivatives and their use as opioid receptor ligands |
| 08/23/2007 | WO2007093602A1 Enantiopure quinuclidinyloxy pyridazines and their use as nicotinic acetylcholine receptor ligands |
| 08/23/2007 | WO2007093601A1 3, 9-diazabicyclo(3.3.1)non-3-yl-aryl methanone derivatives as nicotinic acetylcholine receptor agonists |
| 08/23/2007 | WO2007093600A1 Novel diazabicycloalkane derivatives and their medical use |
| 08/23/2007 | WO2007093587A1 Use of r-(-)-2,4-diamino-5-(2, 3-dichlorophenyl)-6-fluoromethyl pyrimidine for the treatment of psychotic disorders |
| 08/23/2007 | WO2007093540A1 Benzoyl-piperidine derivatives as 5ht2/d3 modulators |
| 08/23/2007 | WO2007093519A2 Ibandronate regimen for treating metastatic bone pain |
| 08/23/2007 | WO2007093183A2 Use of a compound that enhances gabaa-ergic neurotransmission for the treatment of inflammatory diseases |
| 08/23/2007 | WO2007068411A3 Therapeutic vaccine |
| 08/23/2007 | WO2007066068A3 Calcium ion channel receptor antagonist |
| 08/23/2007 | WO2007065619A3 Foam wafer containing a polyvinyl alcohol-polyethyleneglycol-graft copolymer |
| 08/23/2007 | WO2007065595A3 Xanthine derivatives, processes for preparing them and their uses |
| 08/23/2007 | WO2007056460A3 Treatment of length dependent neuropathy |
| 08/23/2007 | WO2007045432A3 Srf as a diagnostic and/or therapeutic target for diseases that are associated with neuronal abnormalities |
| 08/23/2007 | WO2007023310A3 Stimulation of neurogenesis with help of alk inhibitors |
| 08/23/2007 | WO2007020459A3 Antisense oligonucleotides against protein kinase isoforms alpha, beta and gamma |
| 08/23/2007 | WO2006134457A8 2,5-bis-diamimne [1 , 4] benzoquinone-derivatives |
| 08/23/2007 | WO2006123930A3 Nucleic acids and polypeptides that are useful in controlling neuronal regeneration |